By providing faster peptide and protein liquid chromatography (FP2LC), the benefits of porous-shell columns are now available to scientists who are tasked to advance our knowledge about the living world.
With increasing industry interest and investment and rising demand from the medical community for these unique, targeted therapies, there is a growing requirement to develop high-throughput analytical techniques to expand biotherapeutic product lines.